RxDoctor Payments Data

Edgar Peithman

Physician Assistant · la Plata, MDNPI 1396745691

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.1% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 34.9% of the total. 2025 is the largest year on record at $896, more than ten times the $60 reported in 2021. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,129in general payments, 2019–2025

Across 181 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Regeneron Healthcare Solutions, Inc.$447
  • UCB, Inc.$372
  • Johnson & Johnson$353
  • Amgen$250
  • Pfizer$138
  • plus $476 from 7 others

What the payments were for

  • Food & beverage$3,00796%
  • Education$1224%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,129 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland →

Medicare billing

Part B allowed, 2024
$261,647
Medicare patients
1,047
Services billed
4,800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab78$285,865
Humira(Cf) PenAdalimumab15$206,710
Cosentyx Sensoready (2 Pens)Secukinumab20$168,087
Humira PenAdalimumab14$93,042
Clobetasol Propionate116$12,014
Cyclosporine13$6,772
Fluorouracil72$5,202
Minocycline Hcl67$3,173
Betamethasone Valerate108$3,057
Triamcinolone Acetonide216$2,988
Tretinoin39$2,690
Hydrocortisone104$1,512
Fluocinolone AcetonideFluocinolone/Shower Cap17$1,511
Metronidazole20$1,368
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip48$1,142

Paid to pharmacies, not to this prescriber.

Other physician assistant in la Plata

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →